Cystic Fibrosis-related Diabetes Is Associated with Worse Lung Function Trajectory despite Ivacaftor Use

被引:5
作者
Bengtson, Charles D. [1 ]
He, Jianghua [1 ]
Kim, Michael D. [1 ]
Salathe, Matthias A. [1 ]
机构
[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
关键词
EPIDEMIOLOGY;
D O I
10.1164/rccm.202104-1060LE
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:1343 / 1345
页数:4
相关论文
共 9 条
  • [1] Knapp EA, 2016, ANN AM THORAC SOC, V13, P1173, DOI 10.1513/AnnalsATS.201511-781OC
  • [2] Epidemiology of cystic fibrosis-related diabetes
    Marshall, BC
    Butler, SM
    Stoddard, M
    Moran, AM
    Liou, TG
    Morgan, WJ
    [J]. JOURNAL OF PEDIATRICS, 2005, 146 (05) : 681 - 687
  • [3] Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
    Middleton, P. G.
    Mall, M. A.
    Drevinek, P.
    Lands, L. C.
    McKone, E. F.
    Polineni, D.
    Ramsey, B. W.
    Taylor-Cousar, J. L.
    Tullis, E.
    Vermeulen, F.
    Marigowda, G.
    Mckee, C. M.
    Moskowitz, S. M.
    Nair, N.
    Savage, J.
    Simard, C.
    Tian, S.
    Waltz, D.
    Xuan, F.
    Rowe, S. M.
    Jain, R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (19) : 1809 - 1819
  • [4] Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline
    Milla, CE
    Warwick, WJ
    Moran, A
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (03) : 891 - 895
  • [5] Epidemiology, Pathophysiology, and Prognostic Implications of Cystic Fibrosis-Related Diabetes A technical review
    Moran, Antoinette
    Becker, Dorothy
    Casella, Samuel J.
    Gottlieb, Peter A.
    Kirkman, M. Sue
    Marshall, Bruce C.
    Slovis, Bonnie
    [J]. DIABETES CARE, 2010, 33 (12) : 2677 - 2683
  • [6] Adherence to lumacaftor-ivacaftor therapy in patients with cystic fibrosis in France
    Olivereau, Lucie
    Nave, Viviane
    Garcia, Stephan
    Perceval, Marie
    Rabilloud, Muriel
    Durieu, Isabelle
    Reynaud, Quitterie
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (03) : 402 - 406
  • [7] A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
    Ramsey, Bonnie W.
    Davies, Jane
    McElvaney, N. Gerard
    Tullis, Elizabeth
    Bell, Scott C.
    Drevinek, Pavel
    Griese, Matthias
    McKone, Edward F.
    Wainwright, Claire E.
    Konstan, Michael W.
    Moss, Richard
    Ratjen, Felix
    Sermet-Gaudelus, Isabelle
    Rowe, Steven M.
    Dong, Qunming
    Rodriguez, Sally
    Yen, Karl
    Ordonez, Claudia
    Elborn, J. Stuart
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (18) : 1663 - 1672
  • [8] Tsabari Reuven, 2016, J Cyst Fibros, V15, pe25, DOI 10.1016/j.jcf.2015.10.012
  • [9] Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries
    Volkova, Nataliya
    Moy, Kristin
    Evans, Jennifer
    Campbell, Daniel
    Tian, Simon
    Simard, Christopher
    Higgins, Mark
    Konstan, Michael W.
    Sawicki, Gregory S.
    Elbert, Alexander
    Charman, Susan C.
    Marshall, Bruce C.
    Bilton, Diana
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (01) : 68 - 79